Interim report
Page 1
Note : This document has been translated from the Japanese original for reference purposes only . In the event of any discrepancy between this translated document and the Japanese original , the original shall prevail . Accounting Standards Fo Wards Foundation FASF MEMBERSHIP August 7 , 2026 Consolidated Financial Results for the Three - Months Period of Fiscal 2026 ( Three - Month Period Ended June 30 , 2026 ) [ JGAAP ] Company name : Stock exchange listing : KAKEN PHARMACEUTICAL CO . , LTD . Tokyo Stock Exchange Securities code number : 4521 URL : Contact : https://www.kaken.co.jp/english/ Representative : Telephone : Hiroyuki Horiuchi , President and Representative Director Yasuhiko Kondo , Director , Head of Accounting & Finance Department + 81-3-5977-5007 Scheduled date of dividend payment commencement : Supplementary materials for financial results : Financial results briefing : Yes None ( Amounts are rounded down to the nearest million yen ) 1. Consolidated Financial Results for the Three - Month Period of Fiscal 2026 ( April 1 , 2026 to June 30 , 2026 ) ( Percentage indicates year - on - year change ) ( 1 ) Consolidated Operating Results ( cumulative ) Profit attributable to Net sales Operating profit Ordinary profit owners of the parent ( Million yen ) ( % ) ( Million yen ) ( % ) ( Million yen ) ( % ) ( Million yen ) ( % ) Three - Month period of Fiscal 30,154 59.8 10,902 11,258 8,439 2026 Three - Month period of Fiscal 18,867 3.4 14 ( 99.5 ) 417 ( 86.1 ) 271 ( 84.5 ) 2025 Note : Comprehensive income : Three - Month period of Fiscal 2026 : Three - Month period of Fiscal 2025 : Three - Month period of Fiscal 2026 Three - Month period of Fiscal ¥ 8,880 million [ - % ] ¥ 40 million [ ( 97.5 ) % ] Basic earnings per share ( Yen ) 222.86 Diluted earnings per share ( Yen ) 2025 7.13 1
Page 2
2 (2) Consolidated Financial Position Total assets Net assets Equity-to-asset ratio (Million yen) (Million yen) (%) As of June 30, 2026 187,414 152,883 81.6 As of March 31, 2026 178,217 147,619 82.8 Reference: Equity: As of June 30, 2026: ¥ 152,883 million As of March 31, 2026: ¥ 147,619 million 2. Cash Dividends Annual dividends per share 1st quarter 2nd quarter 3rd quarter Year-end Total (Yen) (Yen) (Yen) (Yen) (Yen) Year ended March 31, 2026 – 95.00 – 95.00 190.00 Year ending March 31, 2027 – Year ending March 31, 2027 (Forecast) 0.00 – 0.00 0.00 Note: Revisions to the forecast of cash dividends most recently announced: None. 3. Consolidated Financial Forecast for Fiscal Year Ending March 31, 2027 (April 1, 2026 to March 31, 2027) (Percentage indicates year-on-year change) Net sales Operating profit Ordinary profit Profit attributable to owners of the parent Basic earnings per share (Million yen) (%) (Million yen) (%) (Million yen) (%) (Million yen) (%) (Yen) Year ending March 31, 2027 89,900 16.9 7,900 – 8,600 – 6,500 203.1 171.65 Note: Revisions to the financial forecast most recently announced: None * For the fiscal year ended March 31, 2026, the Company recorded an operating loss of ¥899 million and an ordinary loss of ¥206 million.
Page 3
3 * Notes (1) Significant changes in the scope of consolidation during the period: None (2) Adoption of accounting treatment specific to the preparation of quarterly consolidated financial statements: Yes (3) Changes in accounting policies, changes in accounting estimates, and restatement 1) Changes in accounting policies due to revisions to accounting standards and other regulations: None 2) Changes in accounting policies other than 1): None 3) Changes in accounting estimates: None 4) Restatement: None (4) Number of issued shares (common stock) 1) Number of issued shares at the end of the period (including treasury stock) As of June 30, 2026 44,139,730 shares As of March 31, 2026 44,139,730 shares 2) Number of treasury shares at the end of the period As of June 30, 2026 6,271,571 shares As of March 31, 2026 6,271,415 shares 3) Average number of shares during the period Three-Month period of Fiscal 2026 37,868,209 shares Three-Month period of Fiscal 2025 38,042,686 shares Note: The number of treasury shares at the end of the period includes the Company’s shares held by the “Board Benefit Trust (BBT)” and the “Employee Stock Ownership Plan (J-ESOP)” (199,700 shares as of June 30, 2026 and 199,700 shares as of March 31, 2026). The Company’s shares held by the BBT and J-ESOP are included in the number of treasury shares to be deducted in the calculation of the average number of shares during the period (199,700 shares as of June 30, 2026 and 109,314 shares as of June 30, 2025). * Review of the Japanese-language originals of the attached quarterly consolidated financial results by certified public accountants or an audit corporation: None * Explanation of proper use of earnings forecasts, and other special matters: (Caution regarding forward-looking statements) The performance forecasts and other descriptions on future events presented in this material are based on information currently available and certain assumptions considered to be reasonable. The actual performance may differ from these forecasts. How to review the quarterly supplementary material to the financial results reports: It has been posted on the Company’s web site, along with the quarterly financial results reports.
Page 4
4 2. Consolidated Financial Results for Three-Month Period of Fiscal 2026 (1) Consolidated balance sheets (Millions of yen) Fiscal 2025 (As of March 31, 2026) Three-Month period of Fiscal 2026 (As of June 30, 2026) Assets Current assets Cash and deposits 44,713 52,152 Notes and accounts receivable - trade, and contract assets 19,378 20,357 Marketable securities 5,992 5,991 Merchandise and finished goods 7,567 6,912 Work in process 2,578 3,110 Raw materials and supplies 8,970 9,349 Income taxes refund receivable 2,068 2,068 Consumption taxes refund receivable 1,302 1,472 Other 1,478 1,642 Total current assets 94,051 103,057 Non-current assets Property, plant and equipment Buildings and structures, net 15,780 15,665 Other, net 11,353 11,402 Total property, plant and equipment 27,134 27,068 Intangible assets Goodwill 5,399 5,419 Marketing rights 12,201 12,245 In-process research and development 5,495 5,519 Other 1,195 1,190 Total intangible assets 24,291 24,375 Investments and other assets Investment securities 18,730 18,915 Long-term prepaid expenses 3,091 2,939 Retirement benefit asset 4,846 4,989 Deferred tax assets 5,367 5,343 Other 704 726 Total investments and other assets 32,740 32,913 Total non-current assets 84,166 84,357 Total assets 178,217 187,414
Page 5
5 (Millions of yen) Fiscal 2025 (As of March 31, 2026) Three-Month period of Fiscal 2026 (As of June 30, 2026) Liabilities Current liabilities Notes and accounts payable - trade 7,428 7,625 Electronically recorded obligations - operating 138 133 Short-term bank loans 3,850 3,850 Income taxes payable 248 3,078 Provision for bonuses 1,019 494 Other 8,119 9,446 Total current liabilities 20,803 24,628 Non-current liabilities Provision for share -based remuneration for employees 61 60 Provision for share-based remuneration 196 196 Net defined benefit liability 4,716 4,804 Deferred tax liabilities 4,405 4,435 Other 414 406 Total non-current liabilities 9,794 9,902 Total liabilities 30,597 34,531 Net assets Shareholders’ equity Common stock 23,853 23,853 Capital surplus 11,406 11,406 Retained earnings 125,625 130,448 Treasury stock (23,776) (23,776) Total shareholders’ equity 137,109 141,932 Accumulated other comprehensive income Net unrealized holding gain on securities 6,806 6,938 Foreign currency translation adjustment 754 1,154 Remeasurements of defined benefit plans 2,949 2,858 Total accumulated other comprehensive income 10,509 10,950 Total net assets 147,619 152,883 Total liabilities and net assets 178,217 187,414
Page 6
6 (2) Consolidated statements of income and comprehensive income (Consolidated statements of income) (Three-Month period of Fiscal 2025 and 2026) (Millions of yen) Three-Month period of Fiscal 2025 (April 1, 2025 – June 30, 2025) Three-Month period of Fiscal 2026 (April 1, 2026 – June 30, 2026) Net sales 18,867 30,154 Cost of sales 8,995 9,183 Gross profit 9,872 20,970 Selling, general and administrative expenses Salaries 1,418 1,519 Bonuses and provision for bonuses 269 297 Retirement benefit expenses 43 (16) Research and development expenses 5,382 4,599 Other 2,744 3,668 Total selling, general and administrative expenses 9,858 10,067 Operating profit 14 10,902 Other income Interest income 43 86 Dividends income 316 307 Foreign exchange gains 57 – Other 9 14 Total other income 428 408 Other expenses Interest expenses 10 14 Foreign exchange losses – 29 Loss on investments in investment partnership 7 6 Other 6 2 Total other expenses 24 52 Ordinary profit 417 11,258 Extraordinary income Other 1 0 Total extraordinary income 1 0 Extraordinary losses Loss on retirement of non-current assets 4 13 Loss on valuation of investment securities 2 2 Other 2 – Total extraordinary losses 9 15 Profit before income taxes 409 11,242 Income taxes 137 2,803 Profit 271 8,439 Profit attributable to owners of the parent 271 8,439
Page 7
7 (Consolidated statements of comprehensive income) (Three-Month period of Fiscal 2025 and 2026) (Millions of yen) Three-Month period of Fiscal 2025 (April 1, 2025 – June 30, 2025) Three-Month period of Fiscal 2026 (April 1, 2026 – June 30, 2026) Profit 271 8,439 Other comprehensive income Net unrealized holding gain on securities (196) 132 Foreign currency translation adjustment – 399 Remeasurements of defined benefit plans (34) (91) Total other comprehensive income (230) 441 Comprehensive income 40 8,880 Total comprehensive income attributable to owners of the parent 40 8,880